Document Detail


Endothelial cell loss: Biaxial small-incision torsional phacoemulsification versus biaxial small-incision longitudinal phacoemulsification.
MedLine Citation:
PMID:  22980723     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To compare clinical results of biaxial small-incision torsional phacoemulsification and biaxial small-incision longitudinal phacoemulsification.
SETTING: Department of Ophthalmology, School of Medicine, Namik Kemal University, Tekirdag, Turkey.
DESIGN: Randomized controlled clinical trial.
METHODS: Eyes with high-density nuclear cataract were assigned to have biaxial longitudinal (microburst mode) or biaxial torsional phacoemulsification. The main outcomes included corrected distance visual acuity (CDVA), central corneal thickness (CCT), central endothelial cell density (ECD), total ultrasound time (UST), cumulative dissipated energy (CDE), percentage total equivalent power in position 3, and balanced salt solution volume. Postoperative follow-up was at 1 day, 1 week, and 1 and 3 months.
RESULTS: Each group comprised 35 patients (35 eyes). Three months postoperatively, the mean CDVA for each group was 0.02 logMAR and the mean CCT returned to the preoperative level (P=.589 and P=.554, respectively). During the postoperative follow-up, the percentage of mean endothelial cell loss in both groups was between 35.4% and 39.1%; there was no statistically significant difference between the groups (P>.05). The mean CDE, UST, percentage total equivalent power in position 3, and balanced salt solution volume values were similar in the 2 groups (P>.05).
CONCLUSION: The risk for high endothelial cell loss should be considered when the phacoemulsification of high-density nuclear cataracts is performed using either method.
FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
Authors:
Tansu Gonen; Ozkan Sever; Fatih Horozoglu; Mustafa Yasar; Kadircan H Keskinbora
Related Documents :
23161343 - Impact of a multidisciplinary standardized clinical pathway on perioperative outcomes i...
24456863 - Paraincisional subcutaneous infusion of ropivacaine after open abdominal vascular surge...
14652123 - Evaluation of intense neuromuscular blockade caused by rocuronium using posttetanic cou...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2012-09-13
Journal Detail:
Title:  Journal of cataract and refractive surgery     Volume:  38     ISSN:  1873-4502     ISO Abbreviation:  J Cataract Refract Surg     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-19     Completed Date:  2013-02-21     Revised Date:  2013-04-25    
Medline Journal Info:
Nlm Unique ID:  8604171     Medline TA:  J Cataract Refract Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1918-24     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.
Affiliation:
Namik Kemal University, School of Medicine, Department of Ophthalmology, Tekirdag, Turkey. tansugonen@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Cataract / classification,  pathology
Cell Count
Corneal Endothelial Cell Loss / diagnosis,  etiology*
Endothelium, Corneal / pathology
Female
Humans
Intraoperative Complications
Lens Implantation, Intraocular
Male
Microsurgery / methods
Middle Aged
Phacoemulsification / adverse effects*,  methods
Postoperative Complications
Prospective Studies
Time Factors
Visual Acuity / physiology
Comments/Corrections
Comment In:
J Cataract Refract Surg. 2013 Mar;39(3):481-2   [PMID:  23506935 ]
J Cataract Refract Surg. 2013 Mar;39(3):481   [PMID:  23506936 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other th...
Next Document:  Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma.